BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 3919989)

  • 1. Theophylline kinetics in chronic obstructive airway disease in the elderly.
    Au WY; Dutt AK; DeSoyza N
    Clin Pharmacol Ther; 1985 Apr; 37(4):472-8. PubMed ID: 3919989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetics of theophylline; variability and effect of arterial pH in chronic obstructive lung disease.
    Resar RK; Walson PD; Fritz WL; Perry DF; Barbee RA
    Chest; 1979 Jul; 76(1):11-6. PubMed ID: 36261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose-dependent kinetics of theophylline in adults with pulmonary diseases.
    Massey KL; Gotz VP; Russell WL
    Ther Drug Monit; 1984; 6(3):284-9. PubMed ID: 6506135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetics of intravenous theophylline.
    Chrzanowski FA; Niebergall PJ; Mayock RL; Taubin JM; Sugita ET
    Clin Pharmacol Ther; 1977 Aug; 22(2):188-95. PubMed ID: 884920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of prednisolone on theophylline pharmacokinetics in patients with chronic airflow obstruction.
    Fergusson RJ; Scott CM; Rafferty P; Gaddie J
    Thorax; 1987 Mar; 42(3):195-8. PubMed ID: 3616979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of maintenance theophylline therapy on lung work in severe chronic obstructive pulmonary disease while standing and walking.
    Jenne JW; Siever JR; Druz WS; Solano JV; Cohen SM; Sharp JT
    Am Rev Respir Dis; 1984 Oct; 130(4):600-5. PubMed ID: 6486559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aminophylline in the outpatient management of decompensated chronic obstructive pulmonary disease.
    Murata GH; Gorby MS; Chick TW; Halperin AK
    Chest; 1990 Dec; 98(6):1346-50. PubMed ID: 2123149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose response relation to oral theophylline in severe chronic obstructive airways disease.
    Chrystyn H; Mulley BA; Peake MD
    BMJ; 1988 Dec; 297(6662):1506-10. PubMed ID: 3147048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of theophylline in chronic obstructive lung disease.
    Umut S; Gemicioğlu B; Yildirim N; Barlas A; Ozüner Z
    Int J Clin Pharmacol Ther Toxicol; 1992 May; 30(5):149-52. PubMed ID: 1592541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacokinetics and pharmacodynamics of theophylline in geriatric patients with multiple diseases].
    Mühlberg W; Platt D; Bauer M; Salzner U
    Klin Wochenschr; 1987 Jul; 65(12):551-7. PubMed ID: 3114546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Theophylline clearance in patients with severe chronic obstructive pulmonary disease receiving supplemental oxygen and the effect of acute hypoxemia.
    Cusack BJ; Crowley JJ; Mercer GD; Charan NB; Vestal RE
    Am Rev Respir Dis; 1986 Jun; 133(6):1110-4. PubMed ID: 3717762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Theophylline pharmacokinetics in patients with mild or severe airway obstruction.
    Rizzo A; Mirabella A; Ferrara G; Pipitone P; Bellia V; Bonsignore G
    Bull Eur Physiopathol Respir; 1982; 18(6):811-8. PubMed ID: 6927536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Theophylline: constant-rate infusion predictions.
    Mesquita CA; Sahebjami H; Imhoff T; Thomas JP; Myre SA
    Ther Drug Monit; 1984; 6(2):157-63. PubMed ID: 6740734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Theophylline disposition in tetraplegic man.
    Segal JL; Gordon SK; Eltorai IM
    South Med J; 1987 Jun; 80(6):720-4. PubMed ID: 3589764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circadian changes in the absorption and elimination of theophylline in patients with bronchial obstruction.
    Uematsu T; Follath F; Vozeh S
    Eur J Clin Pharmacol; 1986; 30(3):309-12. PubMed ID: 3732366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Individualized aminophylline therapy in patients with obstructive airway disease: oral dosage prediction from an intravenous test dose.
    Horai Y; Ishizaki T; Sasaki T; Watanabe M; Kabe J
    Eur J Clin Pharmacol; 1982; 23(2):111-21. PubMed ID: 7140800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of age on theophylline clearance in patients with chronic obstructive pulmonary disease.
    Bauer LA; Blouin RA
    Clin Pharmacokinet; 1981; 6(6):469-74. PubMed ID: 7318306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized, controlled trial of theophylline in patients with severe chronic obstructive pulmonary disease.
    Murciano D; Auclair MH; Pariente R; Aubier M
    N Engl J Med; 1989 Jun; 320(23):1521-5. PubMed ID: 2498658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired theophylline clearance in patients with cor pulmonale.
    Vicuna N; McNay JL; Ludden TM; Schwertner H
    Br J Clin Pharmacol; 1979 Jan; 7(1):33-7. PubMed ID: 760740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value of theophylline treatment in patients handicapped by chronic obstructive lung disease.
    McKay SE; Howie CA; Thomson AH; Whiting B; Addis GJ
    Thorax; 1993 Mar; 48(3):227-32. PubMed ID: 8497820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.